文献速递艾滋病与性传播感染

移植与HIV潜伏病毒储存库

Transplantation and the HIV Latent Viral Reservoir.
PubMed 文献 · J Infect Dis · 2026-10-28

尽管接受抗逆转录病毒治疗,潜伏病毒储存库(LVR)仍是HIV治愈的主要障碍。肾移植中T细胞清除者LVR先降后升并最终超过未清除者,HIV阳性肝移植未见对LVR大小的影响。

要点

  • 肾移植中T细胞清除者LVR先降后升,最终超过未清除者。
  • HIV阳性肝移植未影响受者LVR大小。

核心结论

  • 实体器官移植对LVR的影响因移植类型和免疫抑制方案而异。

研究设计与样本

  • 综述性文章,总结造血干细胞移植和实体器官移植对HIV潜伏病毒储存库影响的研究。

主要发现

  • 肾移植受者中,T细胞清除者LVR初始下降后反弹,最终超过未清除者。
  • HIV阳性肝移植未对受者LVR大小产生影响。

临床怎么用

  • 实体器官移植比异基因造血干细胞移植更可及,其LVR研究经验可启示更可行的治愈策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite antiretroviral therapy, the latent viral reservoir (LVR) remains the primary barrier to HIV cure. Both hematopoietic and solid organ transplantation (SOT) have provided optimism for cure and significant insights into LVR composition and maintenance. There have been thirteen reported cases of acquired cure, all in individuals receiving allogeneic hematopoietic stem cell transplants (allo-HSCT). While infeasible for most, these cases have provided important lessons about the LVR. Impacts of SOT on the LVR have also been investigated. In kidney transplantation where recipients were T-cell depleted, the LVR initially decreased before rebounding, and eventually surpassed the LVR of recipients without T-cell depletion. Despite transplanting a large lymphoid organ, studies have found no impact of HIV+ liver transplants on LVR size in recipients. Given that SOTs are more accessible globally than allo-HSCTs, lessons learned about the LVR from these studies can inform potential cure avenues that may be more feasible and attainable.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Howard JN, Smith ML, Balagopal A, et al. Transplantation and the HIV Latent Viral Reservoir. J Infect Dis. 2026. PMID: 42950125. doi:10.1093/infdis/jiag526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。